Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004467
Status:
COMPLETED
Last Update Posted:
2017-10-13
First Post:
1999-10-18
Brief Title:
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Organization:
National Institute of Diabetes and Digestive and Kidney Diseases NIDDK
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
True
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES
I Determine the safety and efficacy of a short course 72 hours of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available
I Determine the safety and efficacy of a short course 72 hours of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available
Detailed Description:
PROTOCOL OUTLINE This is a randomized multicenter study Patients are randomized to receive intravenous acetylcysteine or placebo for 72 hours Treatment must begin within 12 hours of hospitalization Patients who advance to grade III or IV encephalopathy are eligible for liver transplantation
Patients are followed at 3 weeks
Patients are followed at 3 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01DK058369 | NIH | University of Texas Southwest Medical Center | httpsreporternihgovquickSearchU01DK058369 |
| R03DK052827 | NIH | None | None |
| UTSMC-IRB-0697-27200 | OTHER | None | None |
| R01DK058369 | NIH | None | None |